KeyGene

22nd Century Group, Inc. (NASDAQ: XXII), and its global plant research partner KeyGene achieved a breakthrough in their research leading to the successful transformation of the hemp/cannabis plant genome using proprietary plant transformation, regeneration technology and clear...